Christopher P. Shryock - 16 Dec 2025 Form 4 Insider Report for Medline Inc. (MDLN)

Signature
/s/ Nicole Fritz, Attorney-in-Fact
Issuer symbol
MDLN
Transactions as of
16 Dec 2025
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 16:30:16 UTC
Next filing
17 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shryock Christopher P Chief Human Resources Officer C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD /s/ Nicole Fritz, Attorney-in-Fact 06 Mar 2026 0002061070

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDLN Class A Common Stock Award +11,903 $0.000000* 11,903 05 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDLN Incentive Units of Medline Holdings, LP Award +496,049 496,049 16 Dec 2025 Class A Common Stock 496,049 $24.19 See Footnote F2, F3, F4, F5
transaction MDLN Incentive Units of Medline Holdings, LP Award +40,638 40,638 16 Dec 2025 Class A Common Stock 40,638 $27.68 See Footnote F2, F3, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, of which 25% vest on June 15, 2026 and the remaining 75% vest in three equal annual installments beginning on March 1, 2027.
F2 Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of the Issuer's Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
F3 (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of an exchange agreement, dated as of December 16, 2025. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.
F4 These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025.
F5 20% of these Incentive Units have vested, and the remaining 80% vest in four equal annual installments beginning on September 27, 2026.
F6 These Incentive Units vest in five equal annual installments beginning on March 28, 2026.